Neurocrine Biosciences NBIX

3 headline mentions across 300+ news sites in the last 30 days.

Headline mentions3last 30 days

Average tone +0.42 3 positive, 0 negative

Daily news coverage

Bars show how many headlines mentioned Neurocrine Biosciences on each day we took a news snapshot; the line shows their average tone.

+0.42
STAT Plus:Concerns grow on safety issues tied to Neurocrine Biosciences rare disease drug
statnews.com · Nov 05

10-Q
Quarterly report 2026-11-02
8-K
Current report 2026-11-02
SCHEDULE 13G
Passive stake (5%+) 2026-10-30
SCHEDULE 13G/A
Passive stake (5%+) 2026-10-15
8-K
Current report 2026-09-28 · 8-K Item 5.02: Director or officer change
S-8
Employee stock plan registration 2026-07-31
8-K/A
Current report 2026-07-31
10-Q
Quarterly report 2026-07-31
8-K
Current report 2026-07-30
SCHEDULE 13G/A
Passive stake (5%+) 2026-07-27
8-K
Current report 2026-05-28 · 8-K Item 5.02: Director or officer change
8-K
Current report 2026-05-18 · 8-K Item 1.01: Entry into a material agreement

Plus 20 insider trading forms (Forms 3, 4, 5 and 144) in the last 90 days, not listed here.

Watch Neurocrine Biosciences

Pulse Index alerts you when Neurocrine Biosciences files with the SEC, or is mentioned on the YouTube channels, news feeds and websites you follow.

See Premium Most mentioned companies